8-17937354-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006197.4(PCM1):c.317G>A(p.Arg106Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00007 in 1,599,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R106W) has been classified as Uncertain significance.
Frequency
Consequence
NM_006197.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151990Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000391 AC: 9AN: 230244Hom.: 0 AF XY: 0.0000241 AC XY: 3AN XY: 124314
GnomAD4 exome AF: 0.0000732 AC: 106AN: 1447654Hom.: 0 Cov.: 29 AF XY: 0.0000724 AC XY: 52AN XY: 718686
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151990Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74228
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.317G>A (p.R106Q) alteration is located in exon 4 (coding exon 2) of the PCM1 gene. This alteration results from a G to A substitution at nucleotide position 317, causing the arginine (R) at amino acid position 106 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at